台股 » 個股 » 健亞 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

健亞

(4130)
可現股當沖
  • 股價
    21.80
  • 漲跌
    ▼0.15
  • 漲幅
    -0.68%
  • 成交量
    105
  • 產業
    上櫃 生技醫療類股
  • 151人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
健亞 (4130)籌碼相關-永豐金-三民 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

永豐金-三民 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2019/05/10327.75128.2027.6523390.59%
2019/05/0800.00128.0528.20-1342-0.29%
2019/05/07128.0000.0028.0513420.29%
2019/05/0300.00128.4028.25-1351-0.28%
2019/05/02128.05128.3028.1003530.00%
2019/04/3000.00128.0528.00-1355-0.28%
2019/04/29128.15128.5027.9003550.00%
2019/04/2600.00128.5028.30-1353-0.28%
2019/04/25128.4500.0028.4513540.28%
2019/04/24228.60228.7528.5503570.00%
2019/04/23128.60428.8028.55-3358-0.84%
2019/04/1900.00128.8028.80-1364-0.27%
2019/04/15229.0300.0029.0024190.48%
2019/04/1200.00129.3029.10-1423-0.24%
2019/04/10229.3800.0029.3524230.47%
2019/04/0900.00129.1029.70-1419-0.24%
2019/04/08128.8000.0028.8514040.25%
2019/04/0300.00329.0029.00-3403-0.74%
2019/04/01128.7500.0028.7514160.24%
2019/03/29128.7500.0028.9014150.24%
2019/03/28128.9000.0028.9014160.24%
2019/03/2700.00229.3029.15-2422-0.47%
2019/03/22129.2000.0029.2014230.24%
2019/03/21129.50229.6029.50-1421-0.24%
2019/03/19129.3000.0029.3514200.24%
2019/03/15129.600.129.7529.600.94190.21%
2019/03/070.130.7000.0030.850.14050.02%
2019/03/0600.00129.7529.75-1381-0.26%
2019/03/0400.00129.8529.50-1378-0.26%
2019/02/27129.50129.7529.5003770.00%
2019/02/25129.75130.4029.7003760.00%
2019/02/22129.6500.0029.6513790.26%
2019/02/21130.25130.5530.3003750.00%
2019/02/20130.0500.0030.2013700.27%
2019/02/19130.7000.0030.2013630.27%
2019/02/1400.00229.1529.40-2292-0.68%
2019/02/1200.00128.6528.65-1278-0.36%
2019/02/1100.00228.5028.50-2278-0.72%
2019/01/29228.3800.0028.3022810.71%
2019/01/25228.9800.0029.0022980.67%
2019/01/23128.50128.8028.9002950.00%
2019/01/2200.00228.8528.60-2294-0.68%
2019/01/21228.8000.0028.6022950.68%
2019/01/16128.6500.0028.7013030.33%
2019/01/1500.00128.9528.85-1303-0.33%
2019/01/14128.6500.0028.7013040.33%
2019/01/0300.00128.5528.35-1295-0.34%
2019/01/02128.25128.6028.2003040.00%
2018/12/28128.05128.2528.3503200.00%
2018/12/27128.3500.0028.3013800.26%
2018/12/07228.7500.0028.4028920.22%
2018/11/23126.6000.0026.5511,1850.08%
2018/11/0500.00126.5026.25-11,185-0.08%
2018/10/1500.00229.6029.55-21,138-0.18%
2018/10/11328.70128.4528.3021,1240.18%
2018/10/05134.65134.3032.7001,0730.00%
2018/10/02134.6500.0034.3019890.10%
2018/10/01135.50136.0035.5009760.00%
2018/09/2800.00334.4534.85-3909-0.33%
2018/09/27336.15135.0034.9028720.23%
2018/09/11130.90431.0630.95-3471-0.64%
2018/09/10134.201133.7632.60-10437-2.29%
2018/09/071032.00232.0532.0582742.91%
2018/09/0500.00129.1529.05-1212-0.47%
2018/08/20129.00128.6528.6502960.00%
2018/07/0300.00832.5332.20-8877-0.91%
2018/06/13134.8000.0034.8011,5460.06%
2018/06/07235.10235.5035.0501,5560.00%
2018/05/3100.00134.7535.10-11,556-0.06%
2018/05/28234.3800.0034.2021,5430.13%
2018/05/18235.7000.0035.7021,5320.13%
2018/05/17235.9500.0035.9021,5340.13%
2018/05/16236.45437.1336.55-21,527-0.13%
2018/05/15236.28236.1536.1001,5140.00%
2018/05/14136.0500.0036.0011,5160.07%
2018/05/11336.330.136.3035.952.91,5130.19%
2018/05/09137.103037.1636.75-291,495-1.94%
2018/05/0817.137.07137.6037.5016.11,4861.08%
2018/05/04136.1500.0035.9011,4610.07%
2018/05/03137.40137.0536.7001,4640.00%
2018/04/26135.60138.2535.6001,4190.00%
2018/04/25237.2500.0037.2521,3990.14%
2018/04/24136.6000.0036.6511,3850.07%
2018/04/2300.00239.0538.60-21,369-0.15%
2018/04/20137.501438.1037.45-131,363-0.95%
2018/04/19137.6500.0037.6511,3770.07%
2018/04/1800.00136.3036.60-11,357-0.07%
2018/04/1700.000.136.1536.25-0.11,3520.00%
2018/04/12238.9500.0038.8521,3070.15%
2018/04/11238.00238.3539.4501,2760.00%
2018/04/03240.00339.7739.35-11,068-0.09%
2018/04/0200.00138.2537.80-1897-0.11%
2018/03/31337.28538.0337.90-2873-0.23%
2018/03/29338.32238.4837.8018110.12%
2018/03/282.137.71238.3837.950.17590.01%
2018/03/27838.73339.4737.4057160.70%
2018/03/2200.00135.5034.80-1488-0.20%
2018/03/211435.5000.0035.50144752.94%
2018/03/20135.1000.0035.1514440.22%
2018/02/26132.80133.1032.9004100.00%
新藥研發 浩鼎子公司抗癌新藥申請一期臨床 健亞明年完成試驗Anue鉅亨-2022/09/12
健亞 相關文章